Home Behandelprotocollen CMML Richtlijnen en literatuur

Richtlijnen


Klik HIER voor de behandelrichtlijn van chronische myelomonocytaire leukemie (2018) van de EHA en ELN (afgeschermd met inlog). De Nederlandse behandelrichtlijn is in voorbereiding en wordt in 2019 verwacht. 

Literatuur  

  1. Itzykson R. et al. Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations from the European Hematology Association and the European LeukemiaNet. HemaSphere, 2018;2:6
  2. Arber D.A. et al. The 2016 revision of the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 127:2391-2405
  3. Solary E. et al. How I treat CMML. Blood 2017,130;126-136
  4. Selimoglu-Buet D. et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia, Blood 2015, 2015 125: 3618-3626
  5. Malcovati L et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 2013 122:2943-2964
  6. Itzykson R. et al, Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol. 2013 Jul 1;31(19):2428-36
  7. Elena C. et al, Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016 Sep 8;128(10):1408-17
  8. Savona M.R. et al. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults, Blood 2015 125: 1857-1865
  9. Symeonidis A. et al. Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Br. J. Haematol. 2015 Oct;171(2):239-246

Ga terug naar de CMML homepage of lees meer over CMML: Ga terug naar de algemene homepage Behandelprotocollen.